MAM
CLVS

Meeder Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Meeder Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-247
Closed -$2K – 2610
2020
Q1 		$2K Sell
247
-14
-5% -$112 ﹤0.01% 2137
2019
Q4 		$3K Sell
261
-324
-55% -$2.36K ﹤0.01% 1967
2019
Q3 		$2K Buy
585
+331
+130% +$2.68K ﹤0.01% 2012
2019
Q2 		$4K Buy
254
+204
+408% +$3.69K ﹤0.01% 1761
2019
Q1 		$1K Sell
50
-351
-88% -$8.8K ﹤0.01% 1659
2018
Q4 		$7K Buy
+401
New +$8.19K ﹤0.01% 1346
2017
Q3 		– Sell
-309
Closed -$29K – 1801
2017
Q2 		$29K Buy
309
+282
+1,044% +$17.3K ﹤0.01% 761
2017
Q1 		$2K Sell
27
-187
-87% -$11.4K ﹤0.01% 1431
2016
Q4 		$10K Buy
+214
New +$7.53K ﹤0.01% 761
2016
Q3 		– Sell
-6,132
Closed -$84K – 991
2016
Q2 		$84K Buy
+6,132
New +$89.6K 0.01% 680

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return